NCT05564975 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Coyer F, Miles S, Gosley S, Fulbrook P, Sketcher-Baker K, Cook JL, Whitmore J
Pressure injury prevalence in intensive care versus non-intensive care patients: A state-wide comparison. Aust Crit Care. 2017 Sep;30(5):244-250. doi: 10.1016/j.aucc.2016.12.00
Gaspar S, Botelho Guedes F, Vitoriano Budri AM, Ferreira C, Gaspar de Matos M
Hospital-acquired pressure ulcers prevention: What is needed for patient safety? The perceptions of nurse stakeholders. Scand J Caring Sci. 2021 Jun 9. doi: 10.1111/scs.12995.
Krupp AE, Monfre J
Pressure ulcers in the ICU patient: an update on prevention and treatment. Curr Infect Dis Rep. 2015 Mar;17(3):468. doi: 10.1007/s11908-015-0468-7.
Lima Serrano M, González Méndez MI, Carrasco Cebollero FM, Lima Rodríguez JS
Risk factors for pressure ulcer development in Intensive Care Units: A systematic review. Med Intensiva. 2017 Aug - Sep;41(6):339-346. doi: 10.1016/j.medin.2016.09.003. Epub 201
Spruce L
Strategies to Help Prevent Hospital-Acquired Pressure Injuries. AORN J. 2020 Feb;111(2):241-242. doi: 10.1002/aorn.12952.
Stotts NA, Brown DS, Donaldson NE, Aydin C, Fridman M
Eliminating hospital-acquired pressure ulcers: within our reach. Adv Skin Wound Care. 2013 Jan;26(1):13-8. doi: 10.1097/01.ASW.0000425935.94874.41.
Wood J, Brown B, Bartley A, Margarida Batista Custódio Cavaco A, Roberts AP, Santon K, Cook S
Reducing pressure ulcers across multiple care settings using a collaborative approach. BMJ Open Qual. 2019 Aug 20;8(3):e000409. doi: 10.1136/bmjoq-2018-000409.

Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients Based on Machine Learning Algorithm

Details for clinical trial NCT05564975

Clinical trial NCT05564975 - References